316 results
6-K
EX-99.2
NEPTF
Neptune Wellness Solutions Inc
19 May 09
Auditors' Report to the Shareholders
12:00am
, the Company has established its excellence in research and development of marine health ingredients by presenting and gaining acknowledgement of its products … 5,000,000 class B shares, 26,000,000 class C shares and 8,000,000 series 1 warrants. Acasti will finance its activities of research and development as well
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
20 Nov 12
Current report (foreign)
12:00am
and intellectual property. NeuroBio will stick to its business plan and research and development activities will continue as planned, although milestones … on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic
40-F
2008 FY
EX-99.4
NEPTF
Neptune Wellness Solutions Inc
28 Aug 08
Annual report (Canada)
12:00am
international rules with regards to its manufacturing and quality control standards; these expenses were recorded as research and development … into research and development (before deductions of the research and development tax credit). See note 7 to the consolidated financial statements for more
6-K
EX-99.2
NEPTF
Neptune Wellness Solutions Inc
28 May 10
Auditors' Report to the Shareholders
12:00am
reception of a new biomass extract generated from Neptune’s research and development program targeting new vascular and affective health indications … , is as follows:
During 2010 fiscal year, the Company made significant progress in its scientific research and development programs and has achieved several
6-K
EX-99.1
NEPTF
Neptune Wellness Solutions Inc
16 Jul 12
Management Analysis of the Financial Situation
12:00am
of a new biomass extract generated from Neptune’s research and development program targeting new cognitive health indications. The Corporation will also … short-term revenues which will contribute to Acasti’s further research and development projects while establishing a validation of Acasti’s omega-3
6-K
EX-99
gu8 7sc9p8ls
4 Dec 12
Form 6-K Filing Document
12:00am
40-F
EX-99.3
2w0dtnl2yeuves gekz2
28 Aug 08
Annual report (Canada)
12:00am
6-K
vdngt x32faok
3 Oct 07
Neptune Reports Year End Financial Results
12:00am
6-K
EX-99.5
zl7a6lbs ywkqhibezj
28 May 10
Auditors' Report to the Shareholders
12:00am
6-K
EX-99.2
11u5ozdvnur
31 May 11
Current report (foreign)
12:00am
40-F
EX-99.5
g82otbtgrt 0q2e
31 May 11
Annual report (Canada)
12:00am
20-F
jr6bdrf6z6z
31 Aug 09
Annual report (foreign)
12:00am
40-F
EX-99.2
6xmuk2lqul71nj3rfyf
28 Aug 08
Annual report (Canada)
12:00am
40-F
EX-99.2
5awdvjqzba6pjg9pbm3h
31 May 11
Annual report (Canada)
12:00am
6-K
EX-99
jx33uc3
3 Oct 07
Neptune Reports Year End Financial Results
12:00am
6-K
EX-99
d6mlk42whxhk5
10 Oct 13
Form 6-K Filing Document
12:00am
6-K
EX-99.7
r49qv1d
25 May 12
Current report (foreign)
12:00am
6-K
EX-99.1
c8dn2oa
28 Aug 08
Current report (foreign)
12:00am
6-K
EX-99
7dcbmd60xk
13 Nov 12
Form 6-K Filing Document
12:00am
6-K
EX-99
ec5ntog8 8y8
21 Dec 12
Form 6-K Filing Document
12:00am